Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ANI pays $46.5mm for US rights to four of AZ's drugs

Executive Summary

ANI Pharmaceuticals Inc. will pay AstraZeneca PLC $46.5mm in cash, royalties, and sales milestones to acquire the NDAs and US marketing rights to four of AZ’s marketed cardiovascular and oncology products.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing

Related Companies